These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 34844892)

  • 21. POEMS syndrome: update on diagnosis, risk-stratification, and management.
    Dispenzieri A
    Am J Hematol; 2015 Oct; 90(10):951-62. PubMed ID: 26331353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. POEMS syndrome: 2011 update on diagnosis, risk-stratification, and management.
    Dispenzieri A
    Am J Hematol; 2011 Jul; 86(7):591-601. PubMed ID: 21681783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. POEMS syndrome: update on diagnosis, risk-stratification, and management.
    Dispenzieri A
    Am J Hematol; 2012 Aug; 87(8):804-14. PubMed ID: 22806697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. POEMS neuropathy: optimising diagnosis and management.
    Keddie S; D'Sa S; Foldes D; Carr AS; Reilly MM; Lunn MPT
    Pract Neurol; 2018 Aug; 18(4):278-290. PubMed ID: 29511110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. POEMS syndrome: A multisystem clonal disorder.
    Ali T; Qazilbash MH
    Eur J Haematol; 2021 Jan; 106(1):14-18. PubMed ID: 32889731
    [TBL] [Abstract][Full Text] [Related]  

  • 26. POEMS syndrome: experience with fourteen cases.
    Singh D; Wadhwa J; Kumar L; Raina V; Agarwal A; Kochupillai V
    Leuk Lymphoma; 2003 Oct; 44(10):1749-52. PubMed ID: 14692529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of bortezomib, cyclophosphamide, and dexamethasone for newly diagnosed POEMS syndrome patients.
    Fang F; Lan XX; Hu RH; Hui WH; Zhao H; Guo YX; Ji BX; Liu HJ; Su L; Sun WL
    Ther Adv Neurol Disord; 2024; 17():17562864231219151. PubMed ID: 38288324
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical characteristics and the long-term outcome of patients with atypical POEMS syndrome variant with undetectable monoclonal gammopathy.
    He T; Zhao A; Zhao H; Cai H; Feng J; Zhang L; Cao X; Zhou D; Li J
    Ann Hematol; 2019 Mar; 98(3):735-743. PubMed ID: 30612232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. POEMS syndrome: 2014 update on diagnosis, risk-stratification, and management.
    Dispenzieri A
    Am J Hematol; 2014 Feb; 89(2):214-23. PubMed ID: 24532337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dramatic improvement of POEMS syndrome following autologous haematopoietic cell transplantation.
    Rovira M; Carreras E; Bladé J; Graus F; Valls J; Fernández-Avilés F; Montserrat E
    Br J Haematol; 2001 Nov; 115(2):373-5. PubMed ID: 11703338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. POEMS syndrome: radiographic appearance with MRI correlation.
    Chong ST; Beasley HS; Daffner RH
    Skeletal Radiol; 2006 Sep; 35(9):690-5. PubMed ID: 16247640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of autologous peripheral blood stem cell transplantation in POEMS syndrome with polyneuropathy.
    Imai N; Kitamura E; Tachibana T; Konishi T; Suzuki Y; Serizawa M; Okabe T; Fujita H
    Intern Med; 2007; 46(3):135-8. PubMed ID: 17268130
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-BCMA CAR-T cells for treatment of plasma cell dyscrasia: case report on POEMS syndrome and multiple myeloma.
    Xu J; Wang Q; Xu H; Gu C; Jiang L; Wang J; Wang D; Xu B; Mao X; Wang J; Wang Z; Xiao Y; Zhang Y; Li C; Zhou J
    J Hematol Oncol; 2018 Oct; 11(1):128. PubMed ID: 30348186
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-dose therapy and autologous stem cell transplantation in patients with POEMS syndrome: a retrospective study of the Plasma Cell Disorder sub-committee of the Chronic Malignancy Working Party of the European Society for Blood & Marrow Transplantation.
    Cook G; Iacobelli S; van Biezen A; Ziagkos D; LeBlond V; Abraham J; McQuaker G; Schoenland S; Rambaldi A; Halaburda K; Rovira M; Sica S; Byrne J; Sanz RG; Nagler A; van de Donk NW; Sinisalo M; Cook M; Kröger N; De Witte T; Morris C; Garderet L
    Haematologica; 2017 Jan; 102(1):160-167. PubMed ID: 27634201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A review of POEMS syndrome.
    Dispenzieri A; Buadi FK
    Oncology (Williston Park); 2013 Dec; 27(12):1242-50. PubMed ID: 24624542
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A man with plasma cell dyscrasia and polyneuropathy due to POEMS syndrome].
    Driessens SK; Wildiers H; Verhoef GE; Vanstraelen D; Robberecht W; Vandenberghe P
    Ned Tijdschr Geneeskd; 2002 Feb; 146(7):321-5. PubMed ID: 11876037
    [TBL] [Abstract][Full Text] [Related]  

  • 37. POEMS Syndrome: Therapeutic Options.
    Jaccard A
    Hematol Oncol Clin North Am; 2018 Feb; 32(1):141-151. PubMed ID: 29157615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. POEMS Syndrome: Bone Marrow, Laboratory, and Clinical Findings in 24 Korean Patients.
    Shim H; Seol CA; Park CJ; Cho YU; Seo EJ; Lee JH; Yoon DH; Suh CW; Park SH; Jang S
    Ann Lab Med; 2019 Nov; 39(6):561-565. PubMed ID: 31240884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical characteristics, risk factors, and outcomes of POEMS syndrome: A longitudinal cohort study.
    Keddie S; Foldes D; Caimari F; Baldeweg SE; Bomsztyk J; Ziff OJ; Fehmi J; Cerner A; Jaunmuktane Z; Brandner S; Yong K; Manji H; Carr A; Rinaldi S; Reilly MM; D'Sa S; Lunn MP
    Neurology; 2020 Jul; 95(3):e268-e279. PubMed ID: 32606227
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment for POEMS syndrome: the current status and tasks for the future].
    Misawa S
    Rinsho Shinkeigaku; 2012; 52(11):923-4. PubMed ID: 23196469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.